Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography

Stroke

Volumn 42, Issue 4, 2011, Pages 1132-1134

  Pilz, Stefan ^a,f   Tomaschitz, Andreas ^a   Meinitzer, Andreas ^a   Drechsler, Christiane ^b   Ritz, Eberhard ^c   Krane, Vera ^b   Wanner, Christoph ^b   Böhm, Bernhard O ^d   März, Winfried ^a,c,e  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

amino acids; cerebrovascular; homoarginine; mortality; prospective

Indexed keywords

HOMOARGININE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; FOLLOW UP; HOMOARGININE BLOOD LEVEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

AGED; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HOMOARGININE; HUMANS; MALE; MIDDLE AGED; MORTALITY; RISK FACTORS; STROKE; TIME FACTORS;

EID: 79954637472     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.603035     Document Type: Article

References (11)

1. Ryan WL, Johnson RJ, Dimari S. Homoarginine synthesis by rat kidney. Arch Biochem Biophys. 1969;131:521-526.
2. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari O, Juonala M, Viikari JS, Heiskanen N, Vanninen E, Punnonen K, Heinonen S. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J. 2008;72:1879-1884.
3. Henningsson R, Lundquist I. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol. 1998;275:E500-E506.
4. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87:5193-5197.
5. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension. 1993;22:812-818. (Pubitemid 23358087)
6. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C. Homoarginine, cardiovascular risk, and mortality. Circulation. 2010;122:967-975.
7. Winkelmann BR, Marz W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics. 2001;2:S1-S73.
8. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
9. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61:62-97.
10. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation. 2006;114:16-20.
11. Item CB, Stöckler-Ipsiroglu S, Stromberger C, Mühl A, Alessandrì MG, Bianchi MC, Tosetti M, Fornai F, Cioni G. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet. 2001;69:1127-1133. (Pubitemid 33015826)